Best Pancreatic cancer doctors in Barcelona: TOP 4 doctors

• Dr. Jaume Capdevila specializes in pancreatic cancer treatment, utilizing advanced medical oncology techniques.
• Standard treatment options for pancreatic cancer include surgery, chemotherapy, radiation therapy, targeted therapy, and immunotherapy.
• International training includes a scholarship at Uppsala University Hospital in Sweden.
• Professional memberships: EORTC, ESMO, ENETS, ASCO, GEMCAD, TTD, and GETHI.
• Holds a degree in Medicine and Surgery from the University of Lleida and specialized in Medical Oncology at Santa Creu i Sant Pau Hospital.

• Dr. Carlos Ballesta López specializes in the treatment of pancreatic cancer with over 30 years of experience.
• He is a pioneer in laparoscopic surgery, which reduces pain and recovery time for patients.
• Standard treatments for pancreatic cancer include laparoscopic surgery, chemotherapy, radiation therapy, targeted therapy, and immunotherapy.
• Dr. Ballesta has trained surgeons in advanced laparoscopic techniques in Spain and Latin America.
• He holds a Bachelor of Medicine and Surgery from the University of Granada and is a Medical Specialist in General Surgery and Gastroenterology.

• Dr. Antonio de Lacy Fortuny specializes in pancreatic cancer treatment using advanced minimally invasive techniques.
• Standard treatments include surgical resection, chemotherapy, radiation therapy, and targeted therapy.
• Dr. Antonio de Lacy Fortuny has experience practicing at clinics in Spain, the USA, and several European countries.
• President of the Association of Surgeons-Endoscopists in Europe, committed to improving global surgical standards.
• Member of various international medical communities, societies, and associations, committed to adhering to global best practices.

Dr. Sullivan graduated in Medicine and Surgery from the National University of Rosario in 2005, specializing in Medical Oncology through the MIR at the Santa Creu i Sant Pau Hospital (HSCiSP, 2012) in Barcelona.

She received a post-MIR scholarship from the Ministry of Interior from HSPiSP (2012) and then a pre-doctoral scholarship from ISCiii (Rio Hortega – 2013-2015).

In 2014, he moved to Paris where he obtained a DUERTECC diploma at the Gustave Roussy University Hospital (Villejuif), followed by an ESMO scholarship (Georges Mathé Translator Scholarship), which he received in 2016.

Since January 2017, he has been working on the staff of the Medical Oncology Department of the HSCiSP. In the same year, he obtained his PhD from the Autonomous University of Barcelona.

Since 2015, he has been a member of the Board of Directors of the Spanish Lung Cancer Group (GECP). And since 2022, he has been the coordinator of the HSCiSP Committee on Neuroendocrine Tumors.

In November 2021, she joined the IOR Medical Oncology Service and is actively involved in various research projects in the Pangea Lab under the supervision of Dr. Molina.

Dr. Sullivan is involved in several clinical trials in lung cancer and neuroendocrine tumors, many of which have been presented at various international scientific meetings.

She has participated in national and international conferences and is an author and co-author of research articles published in influential journals.

She is currently a member of the Spanish Society of Medical Oncology (SEOM), GECP, European Society of Medical Oncology (ESMO), American Society of Clinical Oncology (ASCO), European Organization for Research and Treatment of Cancer (EORTC) and the Spanish Group of Neuroendocrine and Endocrine Tumors (GETNE).